Paeds Vivas · cardiology
Exercise evaluation and sports participation in heart disease — branching viva
Branching viva on exercise evaluation and sports participation in heart disease: the red-flag exertional history and family history that halt clearance, the Mitchell dynamic x static sport classification, the layered workup from history and examination through ECG, echocardiography and cardiopulmonary exercise testing, the three eligibility tiers applied across innocent murmurs and repaired lesions through bicuspid valve and repaired tetralogy to hypertrophic cardiomyopathy, channelopathy and anomalous coronary artery, and venue safety with a written emergency action plan and an accessible AED.
On this page
Study tools
Target exams
Branch 1 — The immediate decision (3 minutes)
Examiner: The coach wants this signed today. What do you do, and why? [2]
Candidate: I do not sign the clearance. Syncope that occurs DURING exertion, with no prodrome, combined with a family history of sudden unexplained death before 50, is a red-flag combination that halts clearance. Her rapid recovery does not make this benign — vasovagal syncope has a prodrome of warmth, nausea, and visual disturbance and occurs on standing or after effort, never mid-race. I would arrange a 12-lead ECG (already done, borderline), echocardiography, Holter monitoring, and an exercise stress test to look for exercise-provoked arrhythmia, because the resting ECG and echocardiogram may be normal in the child who collapses on the field. I would refer urgently to paediatric cardiology before any return to sport. [12] [13]
References11ShowHide
- [1]Levine BD, Baggish AL, Kovacs RJ, Link MS, Maron BJ Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact. J Am Coll Cardiol, 2015.PMID 26542656
- [2]Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes. J Am Coll Cardiol, 2015.PMID 26542659
- [3]Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, and Other Cardiomyopathies. J Am Coll Cardiol, 2015.PMID 26542657
- [4]Van Hare GF, Ackerman MJ, Evangelista JK, Kovacs RJ, Myerburg RJ Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease. J Am Coll Cardiol, 2015.PMID 26542660
- [6]Thompson PD, Myerburg RJ, Levine BD, Udelson JE, Kovacs RJ Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease. J Am Coll Cardiol, 2015.PMID 26542666
- [8]Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies. J Am Coll Cardiol, 2015.PMID 26542662
- [9]Link MS, Myerburg RJ, Estes NAM 3rd Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators. J Am Coll Cardiol, 2015.PMID 26542665
- [10]Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J, 2021.PMID 32860412
- [11]Longmuir PE, Brothers JA, de Ferranti SD, Hayman LL, McCrindle BW, et al. Promotion of physical activity for children and adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation, 2013.PMID 23630128
- [12]Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update. Circulation, 2007.PMID 17353433
- [13]Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA, 2006.PMID 17018804